1) Chitosan was grafted with polylactide of different molecular weights, 10 kDa and 60 kDa, to form nanoparticles for co-delivery of doxorubicin and temozolomide. 2) The nanoparticles were characterized and found to have sizes between 150-350 nm and zeta potentials of 25-45 mV, indicating stability. They showed high encapsulation efficiency of the drugs at both acidic and neutral pH. 3) In vitro drug release studies demonstrated sustained release of both drugs over 2 weeks from the nanoparticles, with the rate of release increasing at higher pH. The nanoparticles based on lower molecular weight polylactide released temozolomide faster than doxorubic